27.09.2017
- There is a regulatory expectation that pharmaceutical companies will verify that the excipients produced by their suppliers are to an appropriate level of GMP. This has been...
05.10.2014
- Excipients, together with an active pharmaceutical ingredient (API), are formulated into a final drug that is either prescribed to a patient by a doctor or bought over-the-counter...
06.06.2014
- Latin America continues to be an area of rising investment for the pharmaceutical industry, with Brazil and Mexico leading the way. Not only is Latin America an attractive target...
08.05.2014
- Changing Roles - China's far-reaching presence in the manufacture and supply of active pharmaceutical ingredients (APIs) around the world has long been known. However, with the...
10.09.2013
- Balancing Act - Regulatory hurdles and product quality are not just challenges reserved for speciality chemical companies; chemical distributors must also adhere to the highest...
06.08.2013
- Safety Net - With the increasing threat of counterfeit medicines entering the legitimate supply chain, there is a need to introduce a standardized identification system to...
02.07.2013
- On July 2, the Falsified Medicines Directive (FMD) went into full force: All APIs imported into the EU must be accompanied by written confirmations of quality by the regulatory...
